[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Choroidal Neovascularization Drug Sales Market Report 2017

December 2017 | 111 pages | ID: GBC9DCA952CEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global Choroidal Neovascularization Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Choroidal Neovascularization Drug for these regions, from 2012 to 2022 (forecast), covering
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Global Choroidal Neovascularization Drug market competition by top manufacturers/players, with Choroidal Neovascularization Drug sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Cellphire, Inc.
  • Chrysalis BioTherapeutics, Inc.
  • Cleveland BioLabs, Inc.
  • Cumberland Pharmaceuticals, Inc.
  • Diffusion Pharmaceuticals Inc.
  • Eli Lilly and Company
  • GNI Group Ltd.
  • Humanetics Corporation
  • INSYS Therapeutics, Inc.
  • Meabco A/S
  • Neumedicines Inc.
  • Onconova Therapeutics, Inc.
  • PharmaIN Corporation
  • Pluristem Therapeutics Inc.
  • ProCertus BioPharm Inc.
  • RDD Pharma Ltd.
  • RedHill Biopharma Ltd.
  • RxBio, Inc.
  • Soligenix, Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • AVMOC-001
  • BB-3
  • BBT-007
  • DG-3
  • Entolimod
  • EWA-001
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Clinic
  • Hospital
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Choroidal Neovascularization Drug Sales Market Report 2017

1 CHOROIDAL NEOVASCULARIZATION DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Choroidal Neovascularization Drug
1.2 Classification of Choroidal Neovascularization Drug by Product Category
  1.2.1 Global Choroidal Neovascularization Drug Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Choroidal Neovascularization Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 AVMOC-001
  1.2.4 BB-3
  1.2.5 BBT-007
  1.2.6 DG-3
  1.2.7 Entolimod
  1.2.8 EWA-001
  1.2.9 Others
1.3 Global Choroidal Neovascularization Drug Market by Application/End Users
  1.3.1 Global Choroidal Neovascularization Drug Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 Global Choroidal Neovascularization Drug Market by Region
  1.4.1 Global Choroidal Neovascularization Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Choroidal Neovascularization Drug Status and Prospect (2012-2022)
  1.4.3 China Choroidal Neovascularization Drug Status and Prospect (2012-2022)
  1.4.4 Europe Choroidal Neovascularization Drug Status and Prospect (2012-2022)
  1.4.5 Japan Choroidal Neovascularization Drug Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Choroidal Neovascularization Drug Status and Prospect (2012-2022)
  1.4.7 India Choroidal Neovascularization Drug Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Choroidal Neovascularization Drug (2012-2022)
  1.5.1 Global Choroidal Neovascularization Drug Sales and Growth Rate (2012-2022)
  1.5.2 Global Choroidal Neovascularization Drug Revenue and Growth Rate (2012-2022)

2 GLOBAL CHOROIDAL NEOVASCULARIZATION DRUG COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Choroidal Neovascularization Drug Market Competition by Players/Suppliers
  2.1.1 Global Choroidal Neovascularization Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Choroidal Neovascularization Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Choroidal Neovascularization Drug (Volume and Value) by Type
  2.2.1 Global Choroidal Neovascularization Drug Sales and Market Share by Type (2012-2017)
  2.2.2 Global Choroidal Neovascularization Drug Revenue and Market Share by Type (2012-2017)
2.3 Global Choroidal Neovascularization Drug (Volume and Value) by Region
  2.3.1 Global Choroidal Neovascularization Drug Sales and Market Share by Region (2012-2017)
  2.3.2 Global Choroidal Neovascularization Drug Revenue and Market Share by Region (2012-2017)
2.4 Global Choroidal Neovascularization Drug (Volume) by Application

3 UNITED STATES CHOROIDAL NEOVASCULARIZATION DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 United States Choroidal Neovascularization Drug Sales and Value (2012-2017)
  3.1.1 United States Choroidal Neovascularization Drug Sales and Growth Rate (2012-2017)
  3.1.2 United States Choroidal Neovascularization Drug Revenue and Growth Rate (2012-2017)
  3.1.3 United States Choroidal Neovascularization Drug Sales Price Trend (2012-2017)
3.2 United States Choroidal Neovascularization Drug Sales Volume and Market Share by Players
3.3 United States Choroidal Neovascularization Drug Sales Volume and Market Share by Type
3.4 United States Choroidal Neovascularization Drug Sales Volume and Market Share by Application

4 CHINA CHOROIDAL NEOVASCULARIZATION DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 China Choroidal Neovascularization Drug Sales and Value (2012-2017)
  4.1.1 China Choroidal Neovascularization Drug Sales and Growth Rate (2012-2017)
  4.1.2 China Choroidal Neovascularization Drug Revenue and Growth Rate (2012-2017)
  4.1.3 China Choroidal Neovascularization Drug Sales Price Trend (2012-2017)
4.2 China Choroidal Neovascularization Drug Sales Volume and Market Share by Players
4.3 China Choroidal Neovascularization Drug Sales Volume and Market Share by Type
4.4 China Choroidal Neovascularization Drug Sales Volume and Market Share by Application

5 EUROPE CHOROIDAL NEOVASCULARIZATION DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Choroidal Neovascularization Drug Sales and Value (2012-2017)
  5.1.1 Europe Choroidal Neovascularization Drug Sales and Growth Rate (2012-2017)
  5.1.2 Europe Choroidal Neovascularization Drug Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Choroidal Neovascularization Drug Sales Price Trend (2012-2017)
5.2 Europe Choroidal Neovascularization Drug Sales Volume and Market Share by Players
5.3 Europe Choroidal Neovascularization Drug Sales Volume and Market Share by Type
5.4 Europe Choroidal Neovascularization Drug Sales Volume and Market Share by Application

6 JAPAN CHOROIDAL NEOVASCULARIZATION DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Choroidal Neovascularization Drug Sales and Value (2012-2017)
  6.1.1 Japan Choroidal Neovascularization Drug Sales and Growth Rate (2012-2017)
  6.1.2 Japan Choroidal Neovascularization Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Choroidal Neovascularization Drug Sales Price Trend (2012-2017)
6.2 Japan Choroidal Neovascularization Drug Sales Volume and Market Share by Players
6.3 Japan Choroidal Neovascularization Drug Sales Volume and Market Share by Type
6.4 Japan Choroidal Neovascularization Drug Sales Volume and Market Share by Application

7 SOUTHEAST ASIA CHOROIDAL NEOVASCULARIZATION DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Choroidal Neovascularization Drug Sales and Value (2012-2017)
  7.1.1 Southeast Asia Choroidal Neovascularization Drug Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Choroidal Neovascularization Drug Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Choroidal Neovascularization Drug Sales Price Trend (2012-2017)
7.2 Southeast Asia Choroidal Neovascularization Drug Sales Volume and Market Share by Players
7.3 Southeast Asia Choroidal Neovascularization Drug Sales Volume and Market Share by Type
7.4 Southeast Asia Choroidal Neovascularization Drug Sales Volume and Market Share by Application

8 INDIA CHOROIDAL NEOVASCULARIZATION DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 India Choroidal Neovascularization Drug Sales and Value (2012-2017)
  8.1.1 India Choroidal Neovascularization Drug Sales and Growth Rate (2012-2017)
  8.1.2 India Choroidal Neovascularization Drug Revenue and Growth Rate (2012-2017)
  8.1.3 India Choroidal Neovascularization Drug Sales Price Trend (2012-2017)
8.2 India Choroidal Neovascularization Drug Sales Volume and Market Share by Players
8.3 India Choroidal Neovascularization Drug Sales Volume and Market Share by Type
8.4 India Choroidal Neovascularization Drug Sales Volume and Market Share by Application

9 GLOBAL CHOROIDAL NEOVASCULARIZATION DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Cellphire, Inc.
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Choroidal Neovascularization Drug Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Cellphire, Inc. Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Chrysalis BioTherapeutics, Inc.
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Choroidal Neovascularization Drug Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Cleveland BioLabs, Inc.
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Choroidal Neovascularization Drug Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Cumberland Pharmaceuticals, Inc.
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Choroidal Neovascularization Drug Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Diffusion Pharmaceuticals Inc.
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Choroidal Neovascularization Drug Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Eli Lilly and Company
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Choroidal Neovascularization Drug Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Eli Lilly and Company Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 GNI Group Ltd.
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Choroidal Neovascularization Drug Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 GNI Group Ltd. Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Humanetics Corporation
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Choroidal Neovascularization Drug Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Humanetics Corporation Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 INSYS Therapeutics, Inc.
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Choroidal Neovascularization Drug Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Meabco A/S
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Choroidal Neovascularization Drug Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Meabco A/S Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 Neumedicines Inc.
9.12 Onconova Therapeutics, Inc.
9.13 PharmaIN Corporation
9.14 Pluristem Therapeutics Inc.
9.15 ProCertus BioPharm Inc.
9.16 RDD Pharma Ltd.
9.17 RedHill Biopharma Ltd.
9.18 RxBio, Inc.
9.19 Soligenix, Inc.

10 CHOROIDAL NEOVASCULARIZATION DRUG MAUFACTURING COST ANALYSIS

10.1 Choroidal Neovascularization Drug Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Choroidal Neovascularization Drug
10.3 Manufacturing Process Analysis of Choroidal Neovascularization Drug

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Choroidal Neovascularization Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Choroidal Neovascularization Drug Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL CHOROIDAL NEOVASCULARIZATION DRUG MARKET FORECAST (2017-2022)

14.1 Global Choroidal Neovascularization Drug Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Choroidal Neovascularization Drug Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Choroidal Neovascularization Drug Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Choroidal Neovascularization Drug Price and Trend Forecast (2017-2022)
14.2 Global Choroidal Neovascularization Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Choroidal Neovascularization Drug Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Choroidal Neovascularization Drug Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Choroidal Neovascularization Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Choroidal Neovascularization Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Choroidal Neovascularization Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Choroidal Neovascularization Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Choroidal Neovascularization Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Choroidal Neovascularization Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Choroidal Neovascularization Drug Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Choroidal Neovascularization Drug Sales Forecast by Type (2017-2022)
  14.3.2 Global Choroidal Neovascularization Drug Revenue Forecast by Type (2017-2022)
  14.3.3 Global Choroidal Neovascularization Drug Price Forecast by Type (2017-2022)
14.4 Global Choroidal Neovascularization Drug Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Choroidal Neovascularization Drug
Figure Global Choroidal Neovascularization Drug Sales Volume Comparison (K Pcs) by Type (2012-2022)
Figure Global Choroidal Neovascularization Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure AVMOC-001 Product Picture
Figure BB-3 Product Picture
Figure BBT-007 Product Picture
Figure DG-3 Product Picture
Figure Entolimod Product Picture
Figure EWA-001 Product Picture
Figure Others Product Picture
Figure Global Choroidal Neovascularization Drug Sales Comparison (K Pcs) by Application (2012-2022)
Figure Global Sales Market Share of Choroidal Neovascularization Drug by Application in 2016
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Choroidal Neovascularization Drug Market Size (Million USD) by Regions (2012-2022)
Figure United States Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Choroidal Neovascularization Drug Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Global Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Choroidal Neovascularization Drug Sales Volume (K Pcs) (2012-2017)
Table Global Choroidal Neovascularization Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Global Choroidal Neovascularization Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Choroidal Neovascularization Drug Sales Share by Players/Suppliers
Figure 2017 Choroidal Neovascularization Drug Sales Share by Players/Suppliers
Figure Global Choroidal Neovascularization Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Choroidal Neovascularization Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Choroidal Neovascularization Drug Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Choroidal Neovascularization Drug Revenue Share by Players
Table 2017 Global Choroidal Neovascularization Drug Revenue Share by Players
Table Global Choroidal Neovascularization Drug Sales (K Pcs) and Market Share by Type (2012-2017)
Table Global Choroidal Neovascularization Drug Sales Share (K Pcs) by Type (2012-2017)
Figure Sales Market Share of Choroidal Neovascularization Drug by Type (2012-2017)
Figure Global Choroidal Neovascularization Drug Sales Growth Rate by Type (2012-2017)
Table Global Choroidal Neovascularization Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Choroidal Neovascularization Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Choroidal Neovascularization Drug by Type (2012-2017)
Figure Global Choroidal Neovascularization Drug Revenue Growth Rate by Type (2012-2017)
Table Global Choroidal Neovascularization Drug Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Global Choroidal Neovascularization Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Choroidal Neovascularization Drug by Region (2012-2017)
Figure Global Choroidal Neovascularization Drug Sales Growth Rate by Region in 2016
Table Global Choroidal Neovascularization Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Choroidal Neovascularization Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Choroidal Neovascularization Drug by Region (2012-2017)
Figure Global Choroidal Neovascularization Drug Revenue Growth Rate by Region in 2016
Table Global Choroidal Neovascularization Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Choroidal Neovascularization Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Choroidal Neovascularization Drug by Region (2012-2017)
Figure Global Choroidal Neovascularization Drug Revenue Market Share by Region in 2016
Table Global Choroidal Neovascularization Drug Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Global Choroidal Neovascularization Drug Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Choroidal Neovascularization Drug by Application (2012-2017)
Figure Global Choroidal Neovascularization Drug Sales Market Share by Application (2012-2017)
Figure United States Choroidal Neovascularization Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Choroidal Neovascularization Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table United States Choroidal Neovascularization Drug Sales Volume (K Pcs) by Players (2012-2017)
Table United States Choroidal Neovascularization Drug Sales Volume Market Share by Players (2012-2017)
Figure United States Choroidal Neovascularization Drug Sales Volume Market Share by Players in 2016
Table United States Choroidal Neovascularization Drug Sales Volume (K Pcs) by Type (2012-2017)
Table United States Choroidal Neovascularization Drug Sales Volume Market Share by Type (2012-2017)
Figure United States Choroidal Neovascularization Drug Sales Volume Market Share by Type in 2016
Table United States Choroidal Neovascularization Drug Sales Volume (K Pcs) by Application (2012-2017)
Table United States Choroidal Neovascularization Drug Sales Volume Market Share by Application (2012-2017)
Figure United States Choroidal Neovascularization Drug Sales Volume Market Share by Application in 2016
Figure China Choroidal Neovascularization Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Choroidal Neovascularization Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table China Choroidal Neovascularization Drug Sales Volume (K Pcs) by Players (2012-2017)
Table China Choroidal Neovascularization Drug Sales Volume Market Share by Players (2012-2017)
Figure China Choroidal Neovascularization Drug Sales Volume Market Share by Players in 2016
Table China Choroidal Neovascularization Drug Sales Volume (K Pcs) by Type (2012-2017)
Table China Choroidal Neovascularization Drug Sales Volume Market Share by Type (2012-2017)
Figure China Choroidal Neovascularization Drug Sales Volume Market Share by Type in 2016
Table China Choroidal Neovascularization Drug Sales Volume (K Pcs) by Application (2012-2017)
Table China Choroidal Neovascularization Drug Sales Volume Market Share by Application (2012-2017)
Figure China Choroidal Neovascularization Drug Sales Volume Market Share by Application in 2016
Figure Europe Choroidal Neovascularization Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Choroidal Neovascularization Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Europe Choroidal Neovascularization Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Europe Choroidal Neovascularization Drug Sales Volume Market Share by Players (2012-2017)
Figure Europe Choroidal Neovascularization Drug Sales Volume Market Share by Players in 2016
Table Europe Choroidal Neovascularization Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Europe Choroidal Neovascularization Drug Sales Volume Market Share by Type (2012-2017)
Figure Europe Choroidal Neovascularization Drug Sales Volume Market Share by Type in 2016
Table Europe Choroidal Neovascularization Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Europe Choroidal Neovascularization Drug Sales Volume Market Share by Application (2012-2017)
Figure Europe Choroidal Neovascularization Drug Sales Volume Market Share by Application in 2016
Figure Japan Choroidal Neovascularization Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Choroidal Neovascularization Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Choroidal Neovascularization Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Japan Choroidal Neovascularization Drug Sales Volume Market Share by Players (2012-2017)
Figure Japan Choroidal Neovascularization Drug Sales Volume Market Share by Players in 2016
Table Japan Choroidal Neovascularization Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Choroidal Neovascularization Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan Choroidal Neovascularization Drug Sales Volume Market Share by Type in 2016
Table Japan Choroidal Neovascularization Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Japan Choroidal Neovascularization Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan Choroidal Neovascularization Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia Choroidal Neovascularization Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Choroidal Neovascularization Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Choroidal Neovascularization Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Southeast Asia Choroidal Neovascularization Drug Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Choroidal Neovascularization Drug Sales Volume Market Share by Players in 2016
Table Southeast Asia Choroidal Neovascularization Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Choroidal Neovascularization Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Choroidal Neovascularization Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia Choroidal Neovascularization Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Southeast Asia Choroidal Neovascularization Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Choroidal Neovascularization Drug Sales Volume Market Share by Application in 2016
Figure India Choroidal Neovascularization Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Choroidal Neovascularization Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table India Choroidal Neovascularization Drug Sales Volume (K Pcs) by Players (2012-2017)
Table India Choroidal Neovascularization Drug Sales Volume Market Share by Players (2012-2017)
Figure India Choroidal Neovascularization Drug Sales Volume Market Share by Players in 2016
Table India Choroidal Neovascularization Drug Sales Volume (K Pcs) by Type (2012-2017)
Table India Choroidal Neovascularization Drug Sales Volume Market Share by Type (2012-2017)
Figure India Choroidal Neovascularization Drug Sales Volume Market Share by Type in 2016
Table India Choroidal Neovascularization Drug Sales Volume (K Pcs) by Application (2012-2017)
Table India Choroidal Neovascularization Drug Sales Volume Market Share by Application (2012-2017)
Figure India Choroidal Neovascularization Drug Sales Volume Market Share by Application in 2016
Table Cellphire, Inc. Basic Information List
Table Cellphire, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cellphire, Inc. Choroidal Neovascularization Drug Sales Growth Rate (2012-2017)
Figure Cellphire, Inc. Choroidal Neovascularization Drug Sales Global Market Share (2012-2017
Figure Cellphire, Inc. Choroidal Neovascularization Drug Revenue Global Market Share (2012-2017)
Table Chrysalis BioTherapeutics, Inc. Basic Information List
Table Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Sales Growth Rate (2012-2017)
Figure Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Sales Global Market Share (2012-2017
Figure Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Revenue Global Market Share (2012-2017)
Table Cleveland BioLabs, Inc. Basic Information List
Table Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Sales Growth Rate (2012-2017)
Figure Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Sales Global Market Share (2012-2017
Figure Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Revenue Global Market Share (2012-2017)
Table Cumberland Pharmaceuticals, Inc. Basic Information List
Table Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Sales Growth Rate (2012-2017)
Figure Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Sales Global Market Share (2012-2017
Figure Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Revenue Global Market Share (2012-2017)
Table Diffusion Pharmaceuticals Inc. Basic Information List
Table Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Sales Growth Rate (2012-2017)
Figure Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Sales Global Market Share (2012-2017
Figure Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Revenue Global Market Share (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Choroidal Neovascularization Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Choroidal Neovascularization Drug Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company Choroidal Neovascularization Drug Sales Global Market Share (2012-2017
Figure Eli Lilly and Company Choroidal Neovascularization Drug Revenue Global Market Share (2012-2017)
Table GNI Group Ltd. Basic Information List
Table GNI Group Ltd. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GNI Group Ltd. Choroidal Neovascularization Drug Sales Growth Rate (2012-2017)
Figure GNI Group Ltd. Choroidal Neovascularization Drug Sales Global Market Share (2012-2017
Figure GNI Group Ltd. Choroidal Neovascularization Drug Revenue Global Market Share (2012-2017)
Table Humanetics Corporation Basic Information List
Table Humanetics Corporation Choroidal Neovascularization Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Humanetics Corporation Choroidal Neovascularization Drug Sales Growth Rate (2012-2017)
Figure Humanetics Corporation Choroidal Neovascularization Drug Sales Global Market Share (2012-2017
Figure Humanetics Corporation Choroidal Neovascularization Drug Revenue Global Market Share (2012-2017)
Table INSYS Therapeutics, Inc. Basic Information List
Table INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Sales Growth Rate (2012-2017)
Figure INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Sales Global Market Share (2012-2017
Figure INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Revenue Global Market Share (2012-2017)
Table Meabco A/S Basic Information List
Table Meabco A/S Choroidal Neovascularization Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Meabco A/S Choroidal Neovascularization Drug Sales Growth Rate (2012-2017)
Figure Meabco A/S Choroidal Neovascularization Drug Sales Global Market Share (2012-2017
Figure Meabco A/S Choroidal Neovascularization Drug Revenue Global Market Share (2012-2017)
Table Neumedicines Inc. Basic Information List
Table Onconova Therapeutics, Inc. Basic Information List
Table PharmaIN Corporation Basic Information List
Table Pluristem Therapeutics Inc. Basic Information List
Table ProCertus BioPharm Inc. Basic Information List
Table RDD Pharma Ltd. Basic Information List
Table RedHill Biopharma Ltd. Basic Information List
Table RxBio, Inc. Basic Information List
Table Soligenix, Inc. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Choroidal Neovascularization Drug
Figure Manufacturing Process Analysis of Choroidal Neovascularization Drug
Figure Choroidal Neovascularization Drug Industrial Chain Analysis
Table Raw Materials Sources of Choroidal Neovascularization Drug Major Players in 2016
Table Major Buyers of Choroidal Neovascularization Drug
Table Distributors/Traders List
Figure Global Choroidal Neovascularization Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Choroidal Neovascularization Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Global Choroidal Neovascularization Drug Sales Volume (K Pcs) Forecast by Regions (2017-2022)
Figure Global Choroidal Neovascularization Drug Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Choroidal Neovascularization Drug Sales Volume Market Share Forecast by Regions in 2022
Table Global Choroidal Neovascularization Drug Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Choroidal Neovascularization Drug Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Choroidal Neovascularization Drug Revenue Market Share Forecast by Regions in 2022
Figure United States Choroidal Neovascularization Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Choroidal Neovascularization Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Choroidal Neovascularization Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Choroidal Neovascularization Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Choroidal Neovascularization Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Choroidal Neovascularization Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Choroidal Neovascularization Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Choroidal Neovascularization Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure Global Choroidal Neovascularization Drug Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Choroidal Neovascularization Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Choroidal Neovascularization Drug Revenue Market Share Forecast by Type (2017-2022)
Table Global Choroidal Neovascularization Drug Price (USD/Pcs) Forecast by Type (2017-2022)
Table Global Choroidal Neovascularization Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Choroidal Neovascularization Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories